PSA
37
2
V
54
2
EQR
47
2
TSN
47
3
DHI
40
3
URBN
54
2
IBM
67
2
HSY
50
5
LNC
70
-2
ADT
48
2
COST
53
5
DIS
72
2
XYL
35
2
EXC
53
3
VNO
52
2
AN
52
2
TGT
52
2
AAPL
55
2
VLO
40
-2
KO
44
2
PSA
37
2
V
54
2
EQR
47
2
TSN
47
3
DHI
40
3
URBN
54
2
IBM
67
2
HSY
50
5
LNC
70
-2
ADT
48
2
COST
53
5
DIS
72
2
XYL
35
2
EXC
53
3
VNO
52
2
AN
52
2
TGT
52
2
AAPL
55
2
VLO
40
-2
KO
44
2
Financhill
Back

Spyre Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59

SYRE
Spyre Therapeutics, Inc.

Last Price:
$33.11
Seasonality Move:
14.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Spyre Therapeutics, Inc. Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics, Inc. has on average historically risen by 9.8% based on the past 9 years of stock performance.
  • Spyre Therapeutics, Inc. has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is Spyre Therapeutics, Inc. Stock Undervalued?
    The current Spyre Therapeutics, Inc. [SYRE] share price is $33.05. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics, Inc. has on average historically risen by 9.8% based on the past 9 years of stock performance.

Spyre Therapeutics, Inc. Stock Rating

Buy
59
Spyre Therapeutics, Inc. (SYRE) is a Buy

Is Spyre Therapeutics, Inc. overpriced?

  • Spyre Therapeutics, Inc. has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Spyre Therapeutics, Inc. Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
35.31
52-Week Low:
10.91

Prediction Charts

Market Cap:
2.6B
Price in USD:
33.05
Volume:
292K
Beta:
2.46

Technical Analysis

SMA50:
27.27
SMA100:
21.92
SMA200:
18.78
52-Wk Change:
41.6%

Stock Predictions

  • Is Spyre Therapeutics, Inc. stock public?
    Yes, Spyre Therapeutics, Inc. is a publicly traded company.
  • What is the Spyre Therapeutics, Inc. stock quote today?
    The Spyre Therapeutics, Inc. stock price is 33.05 USD today.
  • How to buy Spyre Therapeutics, Inc. stock online?
    You can buy Spyre Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 33.56 33.45 34.06 33.00
Dec-8 33.95 34.63 34.96 33.45
Dec-9 34.48 33.68 34.98 33.52
Dec-10 33.70 34.66 34.94 33.51
Dec-11 34.77 34.36 35.31 34.17
Dec-12 34.36 33.62 35.17 33.24
Dec-15 33.93 33.34 34.96 33.15
Dec-16 33.00 32.97 33.52 32.26
Dec-17 33.51 33.06 34.32 32.76
Dec-18 33.66 33.47 34.24 32.88
Dec-19 33.82 33.40 34.84 33.22
Dec-22 32.93 34.20 34.52 32.50
Dec-23 33.84 33.23 34.44 32.96
Dec-24 33.38 33.05 34.10 32.79

Spyre Therapeutics, Inc. Earnings

Spyre Therapeutics, Inc. Earnings Report: Per Share Spyre Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics, Inc. Forecast Revenue Growth

Spyre Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.19 per share, and a decrease next year of $0.67 per share.

* Spyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.